Table 1 Participants’ characteristics by sex
| Â | Male | Female |
|---|---|---|
Participants | 24 (18.05%) | 109 (81.95%) |
Age, y | 74.67 (6.26) | 74.68 (5.06) |
IGF-1, ng/mL | 94.38 (26.27) | 89.20 (25.88) |
Albumin, g/dL | 4.28 (0.25) | 4.30 (0.25) |
BMI, kg/m2 | 23.88 (3.19) | 22.77 (3.20) |
SMI, kg/m2 | 7.28 (0.89) | 5.64 (0.64) |
BMD, %YAM | 93.54 (10.81) | 84.92 (10.45) |
Hypertension | 11 (45.83%) | 50 (45.87%) |
Diabetes mellitus | 3 (12.50%) | 7 (7.52%) |
Hyperlipidemia | 7 (29.17%) | 33 (30.28%) |
Osteoporosis | 0 (0%) | 38 (35.19%) |
Osteoarthritis | 1 (4.17%) | 21 (19.27%) |
Fracture after age 60 y | 2 (8.33%) | 19 (17.59%) |
Locomo-25 score, points | 6.38 (6.64) | 8.38 (10.23) |
LS | 8 (33.33%) | 39 (35.78%) |
 LS stage 1 | 4 (16.67%) | 21 (19.27%) |
 LS stage 2 | 4 (16.67%) | 9 (8.26%) |
 LS stage 3 | 0 (0%) | 9 (8.26%) |